Zensights Market Update – March 2024

Zensights Market Update – March 2024

The latest insights on M&A activity in life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...
The Benefits of Public-Private Partnerships

The Benefits of Public-Private Partnerships

Open Summary Report Getting busy with our day-to-day lives, it can become rare to find opportunities for reflection and growth. Every once in a while, you walk away from a conversation with an exceptional individual that leaves you curious, excited, and energized....
Navigating the Veeva-Salesforce Breakup

Navigating the Veeva-Salesforce Breakup

In a significant announcement, Veeva has communicated its decision not to renewits partnership agreement with SalesForce (SFdC) effective September 2025. This development prompts businesses to consider the implications and chart a course forward. While customers are...
Zensights Market Update – November 2023

Zensights Market Update – November 2023

The latest insights on M&A activity in the life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...
Zensights Market Update – August 2023

Zensights Market Update – August 2023

The latest insights on M&A activity in the life sciences commercial vendors As part of our LINX bio-pharma vendor review, Zensights is pleased to share an update on merger activity to help our clients understand the market activity that may impact their supplier...